Gabapentin
Approved · FDAAlso known as 1-(Aminomethyl)cyclohexaneacetic acid, Gabarone, Gralise, Horizant+6 more
1-(Aminomethyl)cyclohexaneacetic acid, Gabarone, Gralise, Horizant, Neurontin, Relgaabi, Gabapentina, Gabapentine, Gabapentino, Gabapentinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Label change: GABAPENTIN (ANDA217995)
Label change: GABAPENTIN (ANDA203934)
Label change: GABAPENTIN (ANDA075428)
Label change: GABAPENTIN (ANDA077661)
Approval: GABAPENTIN (ANDA203611)
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial
Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
- Neurology1
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology1
- Adusumalli M1
- Ames C1
- Bak K1
- Begovic A1
- Bleeker J1
- Buffkins K1
- Cavaletti G1
- Chauhan C1
- Columbia University Medical Center1
- The Scripps Research Institute1
- University of California1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Gabapentin in the shared literature.
Studied across 3 of the same disease areas as Gabapentin in the shared literature.
Studied across 3 of the same disease areas as Gabapentin in the shared literature.
Studied across 3 of the same disease areas as Gabapentin in the shared literature.
Studied across 3 of the same disease areas as Gabapentin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.